Pharmacologic therapy for acute MI in the elderly

R. Forman, W. Aronow

Research output: Contribution to journalReview articlepeer-review


Mortality and morbidity from acute myocardial infarction (MI) are much higher in the elderly than in younger patients, creating a greater potential for improving the outcome with aggressive medical therapy. Elderly patients can benefit significantly from early thrombolysis with relatively few complications; aspirin and heparin-particularly in conjunction with thrombolytic agents-are highly effective. Long-term β-blockade can improve survival markedly, and the use of intravenous angiotensin-converting enzyme inhibitors before discharge decreases both mortality and the risk of heart failure. Early results for magnesium sulfate are promising as well.

Original languageEnglish (US)
Pages (from-to)29-36
Number of pages8
JournalDrug Therapy
Issue number8
StatePublished - Jan 1 1993

ASJC Scopus subject areas

  • Pharmaceutical Science


Dive into the research topics of 'Pharmacologic therapy for acute MI in the elderly'. Together they form a unique fingerprint.

Cite this